Bevers, Nanja https://orcid.org/0000-0003-3646-5670
Aliu, Arta
Rezazadeh Ardabili, Ashkan
Winken, Bjorn
Raijmakers, Maarten
van de Vijver, Els
Donker, Albertine
Swinkels, Dorine
Vreugdenhil, Anita
Pierik, Marieke
van Rheenen, Patrick
Article History
Received: 31 August 2023
Revised: 11 April 2024
Accepted: 4 June 2024
First Online: 30 July 2024
Competing interests
: M.J.P. reports grants and non-financial support from Falk Pharma, grants from the European Commission, grants from ZONMW (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from Abbvie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work.
: This study described secondary analyses of prospectively collected data as part of the POPEYE trial. Informed consent was obtained from all participants at the beginning of the study.